Menu
Back to Journals » Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
Editor-in-Chief: Dr Martin H Bluth
An international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
We are currently seeking expressions of interest for an Associate Editor position and for Editorial Board members for this journal.
Please send your CV and a one-page vision statement detailing your overall objectives for the journal to Emi Kirilova - [email protected]. Please be sure to indicate whether you are interested in the Associate Editor role or a position on the Editorial Board in your application.
Articles:
- View all (614)
- Volume 16, 2023 (90)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Latest articles:
- 5 records -
A Review on Probable Causes of Cardiotoxicity Caused by Common Cancer Drugs and the Role of Traditional Chinese Medicine in Prevention and Treatment
Zhou M, Wang W, Weng J, Lai Z
Pharmacogenomics and Personalized Medicine 2023, 16:1067-1077
Published Date: 6 December 2023
Novel Autophagy-Related Blood Biomarkers Associated with Immune Cell Infiltration in Ankylosing Spondylitis
Song H, Liu H, Li X, Lv B, Tang Z, Chen Q, Zhang D, Wang F
Pharmacogenomics and Personalized Medicine 2023, 16:1055-1066
Published Date: 5 December 2023
Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database
Zhang Y, Chen Y, Chen Z, Zhou X, Chen S, Lan K, Wang Z, Zhang Y
Pharmacogenomics and Personalized Medicine 2023, 16:1041-1053
Published Date: 1 December 2023
Implication of KDR Polymorphism rs2071559 on Therapeutic Outcomes and Safety of Postoperative Patients with Gastric Cancer Who Received S-1-Based Adjuvant Chemotherapy: A Real-World Exploratory Study
Meng L, Cao J, Kang L, Xu G, Yuan DW, Li K, Zhu K
Pharmacogenomics and Personalized Medicine 2023, 16:1027-1039
Published Date: 28 November 2023
Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation
Huang R, Zhang YT, Lin Y, Pang RL, Yang Z, Zhao WH
Pharmacogenomics and Personalized Medicine 2023, 16:1011-1026
Published Date: 11 November 2023